跳至主要内容
临床试验/NCT01761136
NCT01761136已完成4 期

Phase 4 Study of Haemophilus Influenzae Type b Vaccine in Different Injection Site

Beijing Center for Disease Control and Prevention5 个研究点 分布在 1 个国家目标入组 680 人开始时间: 2011年11月1日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
680
试验地点
5
主要终点
Incidence rate of adverse events of Haemophilus influenzae type b vaccine in different injection site

研究概览

简要总结

The objective of this study was to evaluate the safety and immunogenicity of Haemophilus influenzae type b vaccine in different injection site.

详细描述

A randomized trial was conducted in 680 healthy infants with Hib vaccine of two brands. The different sub-groups were selected randomly based on the plan to inoculate vaccines in the upper arm deltoid or vastus lateralis muscle. The safety and immunogenicity were assessed after three or two doses.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
2 Months 至 12 Months(Child)
性别
All
接受健康志愿者

入选标准

  • participants were under 1 years old, and were in good healthy
  • participants were full-time pregnancy and birth weight were more than 2.5 kg

排除标准

  • current infectious fever or acute disease
  • a history of hypersensitivity to study vaccine components especially tetanus toxoid
  • a history of allergy, autoimmune, convulsions, seizures heredity disease
  • a history of Hib vaccination or Hib disease
  • a history of congenital deformity, developmental disorders or serious chronic diseases, muscle injection contradiction, and immunosuppressive agents, hormone or immunoglobulin received.

结局指标

主要结局

Incidence rate of adverse events of Haemophilus influenzae type b vaccine in different injection site

时间窗: one year

次要结局

  • Antibody titre of Haemophilus influenzae type b vaccine in different injection site(one year)

研究者

发起方
Beijing Center for Disease Control and Prevention
申办方类型
Other Gov
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验